DE69325577T2 - Mn-gen und protein - Google Patents
Mn-gen und proteinInfo
- Publication number
- DE69325577T2 DE69325577T2 DE69325577T DE69325577T DE69325577T2 DE 69325577 T2 DE69325577 T2 DE 69325577T2 DE 69325577 T DE69325577 T DE 69325577T DE 69325577 T DE69325577 T DE 69325577T DE 69325577 T2 DE69325577 T2 DE 69325577T2
- Authority
- DE
- Germany
- Prior art keywords
- gene
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS70992 | 1992-03-11 | ||
US07/964,589 US5387676A (en) | 1992-03-11 | 1992-10-21 | MN gene and protein |
PCT/US1993/002024 WO1993018152A1 (en) | 1992-03-11 | 1993-03-08 | Mn gene and protein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69325577D1 DE69325577D1 (de) | 1999-08-12 |
DE69325577T2 true DE69325577T2 (de) | 2000-01-13 |
Family
ID=25745325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69325577T Expired - Lifetime DE69325577T2 (de) | 1992-03-11 | 1993-03-08 | Mn-gen und protein |
Country Status (8)
Country | Link |
---|---|
US (5) | US5387676A (de) |
EP (1) | EP0637336B1 (de) |
JP (3) | JP3755536B2 (de) |
AU (1) | AU669694B2 (de) |
CA (1) | CA2131826C (de) |
DE (1) | DE69325577T2 (de) |
NO (1) | NO314191B1 (de) |
WO (1) | WO1993018152A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008069864A2 (en) | 2006-10-12 | 2008-06-12 | Bayer Pharmaceuticals Corporation | Mn/ca9 splice variants |
EP2508596A2 (de) | 2002-02-21 | 2012-10-10 | Bayer Healthcare | MN/CA-IX-spezifische, von MN/CA-IX-defizienten Mäusen erzeugte monoklonale Antikörper und Verwendungsverfahren |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030206899A1 (en) * | 1991-03-29 | 2003-11-06 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists |
US5989838A (en) * | 1992-03-11 | 1999-11-23 | Institute Of Virology, Slovak Academy Of Sciences | Immunological methods of detecting MN proteins and MN polypeptides |
US5981711A (en) * | 1992-03-11 | 1999-11-09 | Institute Of Virology, Slovak Academy Of Sciences | MN-specific antibodies and hybridomas |
US5972353A (en) * | 1992-03-11 | 1999-10-26 | Institute Of Virology, Slovak Academy Of Sciences | MN proteins, polypeptides, fusion proteins and fusion polypeptides |
US5387676A (en) * | 1992-03-11 | 1995-02-07 | Ciba Corning Diagnostics Corp. | MN gene and protein |
US5955075A (en) * | 1992-03-11 | 1999-09-21 | Institute Of Virology, Slovak Academy Of Sciences | Method of inhibiting tumor growth using antibodies to MN protein |
US6093548A (en) * | 1992-03-11 | 2000-07-25 | Institute Of Virology, Slovak Academy Of Sciences | Detection and quantitation of MN-specific antibodies. |
US6027887A (en) * | 1992-03-11 | 2000-02-22 | Institute Of Virology, Solvak Academy Of Sciences | MN gene and protein |
US6297051B1 (en) | 1997-01-24 | 2001-10-02 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
US6297041B1 (en) * | 1992-03-11 | 2001-10-02 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
US6069242A (en) * | 1992-03-11 | 2000-05-30 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
US6204370B1 (en) * | 1992-03-11 | 2001-03-20 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
US6774117B1 (en) | 1992-03-11 | 2004-08-10 | Institute Of Virology, Slovak Academy Of Sciences | MN gene and protein |
AU2861695A (en) * | 1994-06-15 | 1996-01-05 | Ciba Corning Diagnostics Corp. | Mn gene and protein |
ATE296883T1 (de) * | 1994-06-15 | 2005-06-15 | Inst Virology | Mn-gen und -protein |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
US5858673A (en) * | 1996-06-24 | 1999-01-12 | Charlotte-Mecklenburg Hospital Authority | Method for detecting prostate cells |
US6087098A (en) * | 1997-04-15 | 2000-07-11 | The Trustees Of Columbia University In The City Of New York | Enhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinoma |
US7713704B1 (en) | 1998-10-23 | 2010-05-11 | Institute Of Virology Of The Slovak Academy Of Science | MN gene and protein |
US6379907B1 (en) | 1999-08-05 | 2002-04-30 | The Regents Of The University Of California | Diagnostic method using expression of MN/CA9 protein in AGUS Pap smears |
US6403327B1 (en) | 1999-08-05 | 2002-06-11 | The Regents Of The University Of California | Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears |
US7910691B2 (en) * | 1999-10-22 | 2011-03-22 | Institute Of Virology Of The Slovak Academy Of Sciences | MN gene and protein |
US20100135980A1 (en) * | 2000-10-16 | 2010-06-03 | Rodriguez Victorio C | Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy |
EP1733736B1 (de) | 2001-02-07 | 2015-02-25 | Wilex AG | Verfahren zur Herstellung von rekombinanten Antikörpern gegen Tumore |
US20040077081A1 (en) * | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
WO2002086089A2 (en) * | 2001-04-23 | 2002-10-31 | Quark Biotech, Inc. | The 76a11 polypeptide and uses thereof |
US7378091B2 (en) * | 2001-12-03 | 2008-05-27 | Amgen Fremont Inc. | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
US7910549B2 (en) * | 2001-12-13 | 2011-03-22 | Institute Of Virology Of The Slovak Academy Of Sciences | MN gene and protein |
WO2003068920A2 (en) | 2002-02-13 | 2003-08-21 | Ludwig Institute For Cancer Research | Humanized gm-csf antibodies |
DK1487972T3 (en) * | 2002-02-21 | 2015-10-19 | Inst Virology | MN / CA IX-specific monoclonal antibodies generated from MN / CA IX-poor mice, as well as methods of use. |
US20090162382A1 (en) * | 2002-03-01 | 2009-06-25 | Bernett Matthew J | Optimized ca9 antibodies and methods of using the same |
ATE437235T1 (de) * | 2002-04-16 | 2009-08-15 | Univ California | Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix |
US20030232030A1 (en) * | 2002-06-12 | 2003-12-18 | L'oreal | Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same |
AU2003280442B2 (en) | 2002-07-01 | 2009-02-05 | Wilex Ag | Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas |
US20090252738A1 (en) * | 2002-08-23 | 2009-10-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
SI2594265T1 (sl) | 2002-11-26 | 2016-03-31 | Institute Of Virology Slovak Academy Of Sciences | CA-IX specifični inhibitorji |
US7524634B2 (en) * | 2003-10-16 | 2009-04-28 | Institute Of Virology, Slovak Academy Of Sciences | MN/CA IX and cancer prognosis |
EP1743038A4 (de) * | 2004-05-04 | 2007-11-21 | Bayer Healthcare | Mn/ca ix/ca9 und nierenkrebsprognose |
US7691375B2 (en) | 2004-07-02 | 2010-04-06 | Wilex Ag | Adjuvant theraphy of G250-expressing tumors |
US20090196850A1 (en) | 2005-01-06 | 2009-08-06 | Novo Nordisk A/S | Anti-Kir Combination Treatments and Methods |
DOP2006000277A (es) | 2005-12-12 | 2007-08-31 | Bayer Pharmaceuticals Corp | Anticuerpos anti mn y métodos para su utilización |
US20080038251A1 (en) * | 2006-03-20 | 2008-02-14 | Silvia Pastorekova | MN/CA IX and MAPK inhibition |
US7820159B2 (en) * | 2006-10-31 | 2010-10-26 | Instiute of Virology of the Slovak Academy of Sciences | MN/CA IX and EGFR pathway inhibition |
US8097423B2 (en) * | 2007-07-30 | 2012-01-17 | Institute Of Virology | MN/CA IX and breast cancer therapy |
US7919006B2 (en) * | 2007-10-31 | 2011-04-05 | Freescale Semiconductor, Inc. | Method of anti-stiction dimple formation under MEMS |
EP2219668A1 (de) * | 2007-11-02 | 2010-08-25 | Wilex AG | Bindungsepitope für g250-antikörper |
WO2009059281A1 (en) * | 2007-11-02 | 2009-05-07 | Health Research Inc. | Compositions and methods for using ca9 protein to stimulate an immune response |
ES2632353T3 (es) | 2009-09-15 | 2017-09-12 | Wilex Ag | Detección selectiva de metástasis en carcinoma renal de células claras |
US8993347B2 (en) | 2009-12-17 | 2015-03-31 | Cornell University | Methods for detecting antibodies in mucosal samples and device for sampling mucosal material |
MX363845B (es) | 2013-02-22 | 2019-04-05 | Wilex Ag | Anticuerpo anti-caix para usarse en el tratamiento de carcinoma de células claras renales. |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
WO2016070016A1 (en) | 2014-10-31 | 2016-05-06 | Massachusetts Institute Of Technology | Compositions and methods for forming emulsions |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
CA3156540A1 (en) | 2019-11-05 | 2021-05-14 | Miriam Zatovicova | Humanized anti-ca ix antibodies and methods of their use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
WO1988008854A1 (en) * | 1987-05-06 | 1988-11-17 | Egbert Oosterwijk | Monoclonal antibodies to renal cell carcinoma |
IL162181A (en) * | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5981711A (en) * | 1992-03-11 | 1999-11-09 | Institute Of Virology, Slovak Academy Of Sciences | MN-specific antibodies and hybridomas |
US5387676A (en) * | 1992-03-11 | 1995-02-07 | Ciba Corning Diagnostics Corp. | MN gene and protein |
AU2861695A (en) * | 1994-06-15 | 1996-01-05 | Ciba Corning Diagnostics Corp. | Mn gene and protein |
-
1992
- 1992-10-21 US US07/964,589 patent/US5387676A/en not_active Expired - Lifetime
-
1993
- 1993-03-08 CA CA002131826A patent/CA2131826C/en not_active Expired - Lifetime
- 1993-03-08 DE DE69325577T patent/DE69325577T2/de not_active Expired - Lifetime
- 1993-03-08 EP EP93907263A patent/EP0637336B1/de not_active Expired - Lifetime
- 1993-03-08 AU AU37927/93A patent/AU669694B2/en not_active Expired
- 1993-03-08 JP JP51592893A patent/JP3755536B2/ja not_active Expired - Lifetime
- 1993-03-08 WO PCT/US1993/002024 patent/WO1993018152A1/en active IP Right Grant
- 1993-12-30 US US08/177,093 patent/US6051226A/en not_active Expired - Lifetime
-
1994
- 1994-09-09 NO NO19943344A patent/NO314191B1/no not_active IP Right Cessation
- 1994-11-07 US US08/335,469 patent/US6004535A/en not_active Expired - Lifetime
-
2005
- 2005-10-12 JP JP2005297594A patent/JP4624900B2/ja not_active Expired - Lifetime
-
2007
- 2007-02-13 US US11/706,101 patent/US7816496B2/en not_active Expired - Fee Related
- 2007-10-31 US US11/932,697 patent/US20080221309A1/en not_active Abandoned
-
2010
- 2010-09-08 JP JP2010200720A patent/JP4865896B2/ja not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2508596A2 (de) | 2002-02-21 | 2012-10-10 | Bayer Healthcare | MN/CA-IX-spezifische, von MN/CA-IX-defizienten Mäusen erzeugte monoklonale Antikörper und Verwendungsverfahren |
EP3031910A1 (de) | 2002-02-21 | 2016-06-15 | Institute Of Virology | Mn/ca-ix-spezifische, monoklonale antikörper, die von mn/ca-ix-defizienten mäusen erzeugt sind, und verfahren zur verwendung |
WO2008069864A2 (en) | 2006-10-12 | 2008-06-12 | Bayer Pharmaceuticals Corporation | Mn/ca9 splice variants |
Also Published As
Publication number | Publication date |
---|---|
US20070255043A1 (en) | 2007-11-01 |
US6051226A (en) | 2000-04-18 |
JPH07508160A (ja) | 1995-09-14 |
CA2131826C (en) | 2000-05-16 |
JP2011036254A (ja) | 2011-02-24 |
NO314191B1 (no) | 2003-02-10 |
EP0637336A1 (de) | 1995-02-08 |
JP3755536B2 (ja) | 2006-03-15 |
AU3792793A (en) | 1993-10-05 |
NO943344L (no) | 1994-09-09 |
US5387676A (en) | 1995-02-07 |
AU669694B2 (en) | 1996-06-20 |
WO1993018152A1 (en) | 1993-09-16 |
DE69325577D1 (de) | 1999-08-12 |
US20080221309A1 (en) | 2008-09-11 |
JP4624900B2 (ja) | 2011-02-02 |
EP0637336B1 (de) | 1999-07-07 |
NO943344D0 (no) | 1994-09-09 |
US7816496B2 (en) | 2010-10-19 |
JP2006083179A (ja) | 2006-03-30 |
CA2131826A1 (en) | 1993-09-16 |
JP4865896B2 (ja) | 2012-02-01 |
US6004535A (en) | 1999-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69325577D1 (de) | Mn-gen und protein | |
DE69333042D1 (de) | Protein l und entsprechenden proteinhybriden | |
DE69425782D1 (de) | Hyterosalpingographie und selektive Salpingographie | |
DK91192D0 (da) | Protein | |
DE69523791D1 (de) | Peptid-mischung und produkte davon | |
DE69331967D1 (de) | Gefässstent und zugehörige einführungsvorrichtung | |
DE69415163T2 (de) | ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL | |
DE69529340D1 (de) | Gesteuertes biopsiegerät und analysegerät | |
BR9506832A (pt) | N-pirazolilanilinas e n-pirazolilaminopiridinas | |
DE69526002D1 (de) | Aufladegerät und Aufladevorrichtung | |
DE69302234D1 (de) | Menschliches Prohibitin und Prohibitin kodierende DNS | |
AU2861695A (en) | Mn gene and protein | |
DK132892D0 (da) | Proteiner | |
NO971505D0 (no) | Trofinin og trofininhjelperproteiner | |
KR950700316A (ko) | 재조합 지베렐린 디엔에이(dna) 및 이들의 사용 방법(recombinant gibberellin dna and uses thereof) | |
IL126923A0 (en) | Mammalian tolloid-like gene and protein | |
GB9423372D0 (en) | Proteins and their uses | |
DE69842206D1 (de) | Echounterdrücker und echounterdrückungsverfahren | |
EP0766693A4 (de) | Gene und proteine und parasitproteasen | |
KR960010685A (ko) | 펩티드 및 그 용도 | |
DE69532881D1 (de) | Ecdn - protein und dafuer kodeierende dna | |
ITMI921571A1 (it) | Azaciclo e azabiciclo alchiliden idrossilamine | |
FI1031U1 (fi) | En troakar | |
BR9202070A (pt) | Demulsificador e coagualdor polieletrolito cationico | |
DE69326230T2 (de) | Insertionselemente und amplifizierbare nukleinsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |